SlideShare a Scribd company logo
Understanding changing patterns
of drug use in Georgia:
Implications for service delivery
and policy development
DDavid Otiashvili, M.D.
Irma Kirtadze, M.D.
Addiction Research Center, Alternative Georgia
Global Addiction Conference
Piza, Italy
May 7, 2013
Brief information on Georgia
Indicator Info for 2011
Surface area 69.700 sq km
Population 4.497.6 m
GDP per capita in
PPS
2549.09 euro
Unemployment rate 15.1%
Prison Population
Rate (per 100.000)
524
Drug use
• General population
No data
• Problem drug use
40,000 (95% CI: 39,000-41,000)
prevalence 1.5% among 15-64 years old
• Drugs injected
shift from traditional opium, heroine and
buprenorphine to home-made ATS (“vint”, “jef”) and
opioids (desomorphine, “krokodile”)
Drugs injected
Abuse of over the counter
medications
• 2003 – explosive abuse of poppy seeds
• 2005-2008 – injection use of Coaxil (Tianeptin)
• 2010-2011 – widespread oral consumption of
anticonvulsant Lyrica (Pregabalin)
Common features of Georgian drug
scene
• Drugs use intravenously (no sniffing, smoking or
inhaling)
• Daily dose is low
• Opioids combined with sedatives
• Unstructured poli-drug use is common
Drug use trends shaped by socio-
economic and policy context
• Buprenorphine abuse
• Home-made stimulants
• Home-made opioids
• Poppy seeds, Coaxil, Lyrica
New drugs – new harms
• Injection risk behavior
• Toxicity
• Overdose
New cases of HIV infection, 1990-
2011
306 300
609
911
1082
841
584
338 270
0 0
8
130
285
552 1200
2118 2352
0
500
1000
1500
2000
2500
3000
2003 2004 2005 2006 2007 2008 2009 2010 2011
OST
detox
Treatment response
Treatment response
• No comprehensive treatment approach
– Treatment planning
– Case management
– Continuum of care
• No gender-focused services
12
Drug legislation
• Drug use (trace of controlled substance in urine) is punishable under
the Administrative Code
• Repeated drug use is punishable under the Criminal Code (up to 1
year imprisonment)
• Possession of ANY amount of drugs, regardless of purpose, is
punishable under the Criminal Code
• Tables of quantities of drugs (any amount of amphetamine – 7 to 14
years)
Prison population
0
5000
10000
15000
20000
25000
30000
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
Disproportionate resource allocation
• Coverage of treatment – 6%
• 6,500 adults received health service vs 27,000
episodes of drug testing and police investigation
Major policy reform needed
• 2013 – Drug Policy Coordination Council
• National Drug Strategy
• Action Plan
• Legislative proposal
HEALTH CARE PROFESSIONALS’
ENGAGEMENT CRITICAL!
Thank you
dato@altgeorgia.ge
datohupo@yahoo.com
www.altgeorgia.ge

More Related Content

What's hot

Preventing most overdose deaths would be easy So, why don’t we?
Preventing most overdose deaths would be easy  So, why don’t we?Preventing most overdose deaths would be easy  So, why don’t we?
Preventing most overdose deaths would be easy So, why don’t we?
IDHDP
 
The Changing Geography of Outpatient Procedural Care 3.31.10
The Changing Geography of Outpatient Procedural Care 3.31.10The Changing Geography of Outpatient Procedural Care 3.31.10
The Changing Geography of Outpatient Procedural Care 3.31.10
Leonard Davis Institute of Health Economics
 
critical review_RNTCP1 -
critical review_RNTCP1 -critical review_RNTCP1 -
critical review_RNTCP1 -
Isha Porwal
 
Global AIDS Response Progress Reporting
Global AIDS Response Progress ReportingGlobal AIDS Response Progress Reporting
Current Topics in Global Clinical Research
Current Topics in Global Clinical ResearchCurrent Topics in Global Clinical Research
Current Topics in Global Clinical Research
Mary K.D. D'Rozario
 
Atlas 8e-poster-mena-region
Atlas 8e-poster-mena-regionAtlas 8e-poster-mena-region
Atlas 8e-poster-mena-region
Mohamed Fayek, MD, MPP
 
Regine Daniel Ihlen - Lung Cancer Europe (LUCE) Norway
Regine Daniel Ihlen - Lung Cancer Europe (LUCE) NorwayRegine Daniel Ihlen - Lung Cancer Europe (LUCE) Norway
Regine Daniel Ihlen - Lung Cancer Europe (LUCE) Norway
Cittadinanzattiva onlus
 
NATIONAL SURVEY ON SUBSTANCE USE IN THE GENERAL POPULATION IN GEORGIA 2015
NATIONAL SURVEY ON SUBSTANCE USE IN THE GENERAL POPULATION IN GEORGIA 2015NATIONAL SURVEY ON SUBSTANCE USE IN THE GENERAL POPULATION IN GEORGIA 2015
NATIONAL SURVEY ON SUBSTANCE USE IN THE GENERAL POPULATION IN GEORGIA 2015
Irma Kirtadze M.D.
 
maternal mortality sri lanka data sources for measuring maternal mortality_lo...
maternal mortality sri lanka data sources for measuring maternal mortality_lo...maternal mortality sri lanka data sources for measuring maternal mortality_lo...
maternal mortality sri lanka data sources for measuring maternal mortality_lo...
Institute for Health Metrics and Evaluation - University of Washington
 
Addiction Essay
Addiction EssayAddiction Essay
Addiction Essay
Stephen Malloy
 
Maternal mortality for 181 countries
Maternal mortality for 181 countriesMaternal mortality for 181 countries
WHO European Ministerial Conference on the Prevention and Control of Noncommu...
WHO European Ministerial Conference on the Prevention and Control of Noncommu...WHO European Ministerial Conference on the Prevention and Control of Noncommu...
WHO European Ministerial Conference on the Prevention and Control of Noncommu...
WHO Regional Office for Europe
 
Cost of Foodborne Illnesses: A literature Review
Cost of Foodborne Illnesses: A literature ReviewCost of Foodborne Illnesses: A literature Review
Cost of Foodborne Illnesses: A literature Review
Ali Zein El-Abdeen Kassem
 
Cost of hospitalization for foodborne diseases
Cost of hospitalization for foodborne diseasesCost of hospitalization for foodborne diseases
Cost of hospitalization for foodborne diseases
ILRI
 
Determinants of first line antiretroviral treatment failure in public hospita...
Determinants of first line antiretroviral treatment failure in public hospita...Determinants of first line antiretroviral treatment failure in public hospita...
Determinants of first line antiretroviral treatment failure in public hospita...
Alexander Decker
 
Childhood multidrug-resistant tuberculosis (MDR-TB) in the EU/EEA: an analysi...
Childhood multidrug-resistant tuberculosis (MDR-TB) in the EU/EEA: an analysi...Childhood multidrug-resistant tuberculosis (MDR-TB) in the EU/EEA: an analysi...
Childhood multidrug-resistant tuberculosis (MDR-TB) in the EU/EEA: an analysi...
European Centre for Disease Prevention and Control
 
Towards a ChemSex map: Overview of data and evidence
Towards a ChemSex map: Overview of data and evidenceTowards a ChemSex map: Overview of data and evidence
Towards a ChemSex map: Overview of data and evidence
ReShape
 
maternal mortality sri lanka global mortality landscape_murray_110110_ihme
maternal mortality sri lanka global mortality landscape_murray_110110_ihmematernal mortality sri lanka global mortality landscape_murray_110110_ihme
maternal mortality sri lanka global mortality landscape_murray_110110_ihme
Institute for Health Metrics and Evaluation - University of Washington
 
Social determinants and risk factors for tuberculosis; need for harmonisation...
Social determinants and risk factors for tuberculosis; need for harmonisation...Social determinants and risk factors for tuberculosis; need for harmonisation...
Social determinants and risk factors for tuberculosis; need for harmonisation...
European Centre for Disease Prevention and Control
 
Tom Fahey, Professot of General Practice, RCSI
Tom Fahey, Professot of General Practice, RCSITom Fahey, Professot of General Practice, RCSI
Tom Fahey, Professot of General Practice, RCSI
Investnet
 

What's hot (20)

Preventing most overdose deaths would be easy So, why don’t we?
Preventing most overdose deaths would be easy  So, why don’t we?Preventing most overdose deaths would be easy  So, why don’t we?
Preventing most overdose deaths would be easy So, why don’t we?
 
The Changing Geography of Outpatient Procedural Care 3.31.10
The Changing Geography of Outpatient Procedural Care 3.31.10The Changing Geography of Outpatient Procedural Care 3.31.10
The Changing Geography of Outpatient Procedural Care 3.31.10
 
critical review_RNTCP1 -
critical review_RNTCP1 -critical review_RNTCP1 -
critical review_RNTCP1 -
 
Global AIDS Response Progress Reporting
Global AIDS Response Progress ReportingGlobal AIDS Response Progress Reporting
Global AIDS Response Progress Reporting
 
Current Topics in Global Clinical Research
Current Topics in Global Clinical ResearchCurrent Topics in Global Clinical Research
Current Topics in Global Clinical Research
 
Atlas 8e-poster-mena-region
Atlas 8e-poster-mena-regionAtlas 8e-poster-mena-region
Atlas 8e-poster-mena-region
 
Regine Daniel Ihlen - Lung Cancer Europe (LUCE) Norway
Regine Daniel Ihlen - Lung Cancer Europe (LUCE) NorwayRegine Daniel Ihlen - Lung Cancer Europe (LUCE) Norway
Regine Daniel Ihlen - Lung Cancer Europe (LUCE) Norway
 
NATIONAL SURVEY ON SUBSTANCE USE IN THE GENERAL POPULATION IN GEORGIA 2015
NATIONAL SURVEY ON SUBSTANCE USE IN THE GENERAL POPULATION IN GEORGIA 2015NATIONAL SURVEY ON SUBSTANCE USE IN THE GENERAL POPULATION IN GEORGIA 2015
NATIONAL SURVEY ON SUBSTANCE USE IN THE GENERAL POPULATION IN GEORGIA 2015
 
maternal mortality sri lanka data sources for measuring maternal mortality_lo...
maternal mortality sri lanka data sources for measuring maternal mortality_lo...maternal mortality sri lanka data sources for measuring maternal mortality_lo...
maternal mortality sri lanka data sources for measuring maternal mortality_lo...
 
Addiction Essay
Addiction EssayAddiction Essay
Addiction Essay
 
Maternal mortality for 181 countries
Maternal mortality for 181 countriesMaternal mortality for 181 countries
Maternal mortality for 181 countries
 
WHO European Ministerial Conference on the Prevention and Control of Noncommu...
WHO European Ministerial Conference on the Prevention and Control of Noncommu...WHO European Ministerial Conference on the Prevention and Control of Noncommu...
WHO European Ministerial Conference on the Prevention and Control of Noncommu...
 
Cost of Foodborne Illnesses: A literature Review
Cost of Foodborne Illnesses: A literature ReviewCost of Foodborne Illnesses: A literature Review
Cost of Foodborne Illnesses: A literature Review
 
Cost of hospitalization for foodborne diseases
Cost of hospitalization for foodborne diseasesCost of hospitalization for foodborne diseases
Cost of hospitalization for foodborne diseases
 
Determinants of first line antiretroviral treatment failure in public hospita...
Determinants of first line antiretroviral treatment failure in public hospita...Determinants of first line antiretroviral treatment failure in public hospita...
Determinants of first line antiretroviral treatment failure in public hospita...
 
Childhood multidrug-resistant tuberculosis (MDR-TB) in the EU/EEA: an analysi...
Childhood multidrug-resistant tuberculosis (MDR-TB) in the EU/EEA: an analysi...Childhood multidrug-resistant tuberculosis (MDR-TB) in the EU/EEA: an analysi...
Childhood multidrug-resistant tuberculosis (MDR-TB) in the EU/EEA: an analysi...
 
Towards a ChemSex map: Overview of data and evidence
Towards a ChemSex map: Overview of data and evidenceTowards a ChemSex map: Overview of data and evidence
Towards a ChemSex map: Overview of data and evidence
 
maternal mortality sri lanka global mortality landscape_murray_110110_ihme
maternal mortality sri lanka global mortality landscape_murray_110110_ihmematernal mortality sri lanka global mortality landscape_murray_110110_ihme
maternal mortality sri lanka global mortality landscape_murray_110110_ihme
 
Social determinants and risk factors for tuberculosis; need for harmonisation...
Social determinants and risk factors for tuberculosis; need for harmonisation...Social determinants and risk factors for tuberculosis; need for harmonisation...
Social determinants and risk factors for tuberculosis; need for harmonisation...
 
Tom Fahey, Professot of General Practice, RCSI
Tom Fahey, Professot of General Practice, RCSITom Fahey, Professot of General Practice, RCSI
Tom Fahey, Professot of General Practice, RCSI
 

Viewers also liked

Alternate Care Facility: Developing Medical Surge Capability in King County
Alternate Care Facility:  Developing Medical Surge Capability in King County Alternate Care Facility:  Developing Medical Surge Capability in King County
Alternate Care Facility: Developing Medical Surge Capability in King County
Partners in Emergency Preparedness Conference
 
Equity tips and market analysis for 11 july
Equity tips and market analysis for 11 julyEquity tips and market analysis for 11 july
Equity tips and market analysis for 11 july
TheEquicom Advisory
 
PROPUESTA DE INTERVENCION
PROPUESTA DE INTERVENCIONPROPUESTA DE INTERVENCION
PROPUESTA DE INTERVENCION
SUMA PANQARITA
 
Equity news letter 6 March 2013
Equity news letter 6 March 2013Equity news letter 6 March 2013
Equity news letter 6 March 2013
TheEquicom Advisory
 
Crisis management presentation
Crisis management presentationCrisis management presentation
Crisis management presentation
Nauman Ghias
 
Weekly ananlysis for equity market 28 jan2013
Weekly ananlysis for equity market 28 jan2013Weekly ananlysis for equity market 28 jan2013
Weekly ananlysis for equity market 28 jan2013
TheEquicom Advisory
 
Pertemuan 7
Pertemuan 7Pertemuan 7
Pertemuan 7
Abdi Gunawan
 
Connected.
Connected.Connected.
Connected.
Matthew Winner
 

Viewers also liked (8)

Alternate Care Facility: Developing Medical Surge Capability in King County
Alternate Care Facility:  Developing Medical Surge Capability in King County Alternate Care Facility:  Developing Medical Surge Capability in King County
Alternate Care Facility: Developing Medical Surge Capability in King County
 
Equity tips and market analysis for 11 july
Equity tips and market analysis for 11 julyEquity tips and market analysis for 11 july
Equity tips and market analysis for 11 july
 
PROPUESTA DE INTERVENCION
PROPUESTA DE INTERVENCIONPROPUESTA DE INTERVENCION
PROPUESTA DE INTERVENCION
 
Equity news letter 6 March 2013
Equity news letter 6 March 2013Equity news letter 6 March 2013
Equity news letter 6 March 2013
 
Crisis management presentation
Crisis management presentationCrisis management presentation
Crisis management presentation
 
Weekly ananlysis for equity market 28 jan2013
Weekly ananlysis for equity market 28 jan2013Weekly ananlysis for equity market 28 jan2013
Weekly ananlysis for equity market 28 jan2013
 
Pertemuan 7
Pertemuan 7Pertemuan 7
Pertemuan 7
 
Connected.
Connected.Connected.
Connected.
 

Similar to Understanding changing patterns of drug use in georgia

11H00_3_Michael Farrell.pptx
11H00_3_Michael Farrell.pptx11H00_3_Michael Farrell.pptx
11H00_3_Michael Farrell.pptx
El Viajero
 
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_externalWed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
OPUNITE
 
Substance Abuse and the ED
Substance Abuse and the EDSubstance Abuse and the ED
Substance Abuse and the ED
EMRA Health Policy Committee
 
Embargo version rx15_tt_wed_300_zibbell
Embargo version rx15_tt_wed_300_zibbellEmbargo version rx15_tt_wed_300_zibbell
Embargo version rx15_tt_wed_300_zibbell
OPUNITE
 
Rx15 pdmp tues_330_1_brown_2fondario_3quesinberry
Rx15 pdmp tues_330_1_brown_2fondario_3quesinberryRx15 pdmp tues_330_1_brown_2fondario_3quesinberry
Rx15 pdmp tues_330_1_brown_2fondario_3quesinberry
OPUNITE
 
Why collect data on age and gender. Hege Salvesen Blix (Norway)
Why collect data on age and gender. Hege Salvesen Blix (Norway)Why collect data on age and gender. Hege Salvesen Blix (Norway)
Why collect data on age and gender. Hege Salvesen Blix (Norway)
European Centre for Disease Prevention and Control (ECDC)
 
Harm reduction atma jaya
Harm reduction   atma jayaHarm reduction   atma jaya
Harm reduction atma jaya
Herrupribadi77
 
What Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIVWhat Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIV
European Centre for Disease Prevention and Control
 
Tx 3 hill shuman_oliver
Tx 3 hill shuman_oliverTx 3 hill shuman_oliver
Tx 3 hill shuman_oliver
OPUNITE
 
Ippf webinar srh_hiv_pwud_27_aug2015
Ippf webinar srh_hiv_pwud_27_aug2015Ippf webinar srh_hiv_pwud_27_aug2015
Ippf webinar srh_hiv_pwud_27_aug2015
Lilian Esemere Kayaro
 
IN BRIEF X In 2011, there were 5.1 million drug-related em.docx
IN BRIEF X In 2011, there were 5.1 million drug-related em.docxIN BRIEF X In 2011, there were 5.1 million drug-related em.docx
IN BRIEF X In 2011, there were 5.1 million drug-related em.docx
wilcockiris
 
Rx15 vision wed_200_ondcp_1_labelle_2jones_3spitznas
Rx15 vision wed_200_ondcp_1_labelle_2jones_3spitznasRx15 vision wed_200_ondcp_1_labelle_2jones_3spitznas
Rx15 vision wed_200_ondcp_1_labelle_2jones_3spitznas
OPUNITE
 
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazonRx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
OPUNITE
 
Global implementation of Harm Reduction
Global implementation of Harm ReductionGlobal implementation of Harm Reduction
Global implementation of Harm Reduction
IDHDP
 
Rx16 vs claad_tues_800_group
Rx16 vs claad_tues_800_groupRx16 vs claad_tues_800_group
Rx16 vs claad_tues_800_group
OPUNITE
 
Wesat2202
Wesat2202Wesat2202
Wesat2202
Mohamed Rafique
 
International access and availability of OST and how drug policy can improve ...
International access and availability of OST and how drug policy can improve ...International access and availability of OST and how drug policy can improve ...
International access and availability of OST and how drug policy can improve ...
IDHDP
 
Promoting rational use of antibiotics in low and middle income countries
Promoting rational use of antibiotics in low and middle income countriesPromoting rational use of antibiotics in low and middle income countries
Promoting rational use of antibiotics in low and middle income countries
Institute of Development Studies
 
20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt
ShirazKhokhar1
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
OPUNITE
 

Similar to Understanding changing patterns of drug use in georgia (20)

11H00_3_Michael Farrell.pptx
11H00_3_Michael Farrell.pptx11H00_3_Michael Farrell.pptx
11H00_3_Michael Farrell.pptx
 
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_externalWed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
 
Substance Abuse and the ED
Substance Abuse and the EDSubstance Abuse and the ED
Substance Abuse and the ED
 
Embargo version rx15_tt_wed_300_zibbell
Embargo version rx15_tt_wed_300_zibbellEmbargo version rx15_tt_wed_300_zibbell
Embargo version rx15_tt_wed_300_zibbell
 
Rx15 pdmp tues_330_1_brown_2fondario_3quesinberry
Rx15 pdmp tues_330_1_brown_2fondario_3quesinberryRx15 pdmp tues_330_1_brown_2fondario_3quesinberry
Rx15 pdmp tues_330_1_brown_2fondario_3quesinberry
 
Why collect data on age and gender. Hege Salvesen Blix (Norway)
Why collect data on age and gender. Hege Salvesen Blix (Norway)Why collect data on age and gender. Hege Salvesen Blix (Norway)
Why collect data on age and gender. Hege Salvesen Blix (Norway)
 
Harm reduction atma jaya
Harm reduction   atma jayaHarm reduction   atma jaya
Harm reduction atma jaya
 
What Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIVWhat Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIV
 
Tx 3 hill shuman_oliver
Tx 3 hill shuman_oliverTx 3 hill shuman_oliver
Tx 3 hill shuman_oliver
 
Ippf webinar srh_hiv_pwud_27_aug2015
Ippf webinar srh_hiv_pwud_27_aug2015Ippf webinar srh_hiv_pwud_27_aug2015
Ippf webinar srh_hiv_pwud_27_aug2015
 
IN BRIEF X In 2011, there were 5.1 million drug-related em.docx
IN BRIEF X In 2011, there were 5.1 million drug-related em.docxIN BRIEF X In 2011, there were 5.1 million drug-related em.docx
IN BRIEF X In 2011, there were 5.1 million drug-related em.docx
 
Rx15 vision wed_200_ondcp_1_labelle_2jones_3spitznas
Rx15 vision wed_200_ondcp_1_labelle_2jones_3spitznasRx15 vision wed_200_ondcp_1_labelle_2jones_3spitznas
Rx15 vision wed_200_ondcp_1_labelle_2jones_3spitznas
 
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazonRx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
 
Global implementation of Harm Reduction
Global implementation of Harm ReductionGlobal implementation of Harm Reduction
Global implementation of Harm Reduction
 
Rx16 vs claad_tues_800_group
Rx16 vs claad_tues_800_groupRx16 vs claad_tues_800_group
Rx16 vs claad_tues_800_group
 
Wesat2202
Wesat2202Wesat2202
Wesat2202
 
International access and availability of OST and how drug policy can improve ...
International access and availability of OST and how drug policy can improve ...International access and availability of OST and how drug policy can improve ...
International access and availability of OST and how drug policy can improve ...
 
Promoting rational use of antibiotics in low and middle income countries
Promoting rational use of antibiotics in low and middle income countriesPromoting rational use of antibiotics in low and middle income countries
Promoting rational use of antibiotics in low and middle income countries
 
20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 

More from Irma Kirtadze M.D.

Cost-benefit analysis of Medication Assisted Treatment and Needle-Syringe Pro...
Cost-benefit analysis of Medication Assisted Treatment and Needle-Syringe Pro...Cost-benefit analysis of Medication Assisted Treatment and Needle-Syringe Pro...
Cost-benefit analysis of Medication Assisted Treatment and Needle-Syringe Pro...
Irma Kirtadze M.D.
 
ზიანის შემცირება
ზიანის შემცირებაზიანის შემცირება
ზიანის შემცირება
Irma Kirtadze M.D.
 
ოპიოიდებით და სტიმულატორებით გამოწვეული ზედოზირების ნიშნები
ოპიოიდებით და სტიმულატორებით გამოწვეული ზედოზირების ნიშნებიოპიოიდებით და სტიმულატორებით გამოწვეული ზედოზირების ნიშნები
ოპიოიდებით და სტიმულატორებით გამოწვეული ზედოზირების ნიშნები
Irma Kirtadze M.D.
 
ნალოქსონის გამოყენება ოპიოიდებით ზედოზირებისას
ნალოქსონის გამოყენება ოპიოიდებით ზედოზირებისასნალოქსონის გამოყენება ოპიოიდებით ზედოზირებისას
ნალოქსონის გამოყენება ოპიოიდებით ზედოზირებისას
Irma Kirtadze M.D.
 
Comprehensive Women‐Centered Treatment for Substance Use in Georgia (country)...
Comprehensive Women‐Centered Treatment for Substance Use in Georgia (country)...Comprehensive Women‐Centered Treatment for Substance Use in Georgia (country)...
Comprehensive Women‐Centered Treatment for Substance Use in Georgia (country)...
Irma Kirtadze M.D.
 
საველე სოციალური მუშაობა ნარკოტიკების ინექციურ მომხმარებლებთან (აუთრიჩი)
საველე სოციალური მუშაობა ნარკოტიკების ინექციურ მომხმარებლებთან (აუთრიჩი)საველე სოციალური მუშაობა ნარკოტიკების ინექციურ მომხმარებლებთან (აუთრიჩი)
საველე სოციალური მუშაობა ნარკოტიკების ინექციურ მომხმარებლებთან (აუთრიჩი)
Irma Kirtadze M.D.
 
სარისკო ქცევა, რისკის შეფასება და ქცევის ცვლილების ეტაპები
სარისკო ქცევა, რისკის შეფასება დაქცევის ცვლილების ეტაპებისარისკო ქცევა, რისკის შეფასება დაქცევის ცვლილების ეტაპები
სარისკო ქცევა, რისკის შეფასება და ქცევის ცვლილების ეტაპები
Irma Kirtadze M.D.
 
Drug use patterns among participants in a woman-focused RCT in Georgia
Drug use patterns among participants in a woman-focused RCT in GeorgiaDrug use patterns among participants in a woman-focused RCT in Georgia
Drug use patterns among participants in a woman-focused RCT in Georgia
Irma Kirtadze M.D.
 
 Stigma, violence, and the lack of confidentiality: The need for comprehensi...
 Stigma, violence, and the lack of confidentiality:  The need for comprehensi... Stigma, violence, and the lack of confidentiality:  The need for comprehensi...
 Stigma, violence, and the lack of confidentiality: The need for comprehensi...
Irma Kirtadze M.D.
 
Risk and stigma in seeking care and policy implications
Risk and stigma in seeking care and policy implicationsRisk and stigma in seeking care and policy implications
Risk and stigma in seeking care and policy implications
Irma Kirtadze M.D.
 
Influence of social norms and attitudes on drug use and HIV risk behavior amo...
Influence of social norms and attitudes on drug use and HIV risk behavior amo...Influence of social norms and attitudes on drug use and HIV risk behavior amo...
Influence of social norms and attitudes on drug use and HIV risk behavior amo...
Irma Kirtadze M.D.
 
A formative study of drug-using women in Georgia: Setting the Stage for an RCT
A formative study of drug-using women in Georgia: Setting the Stage for an RCTA formative study of drug-using women in Georgia: Setting the Stage for an RCT
A formative study of drug-using women in Georgia: Setting the Stage for an RCT
Irma Kirtadze M.D.
 
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...
Irma Kirtadze M.D.
 

More from Irma Kirtadze M.D. (13)

Cost-benefit analysis of Medication Assisted Treatment and Needle-Syringe Pro...
Cost-benefit analysis of Medication Assisted Treatment and Needle-Syringe Pro...Cost-benefit analysis of Medication Assisted Treatment and Needle-Syringe Pro...
Cost-benefit analysis of Medication Assisted Treatment and Needle-Syringe Pro...
 
ზიანის შემცირება
ზიანის შემცირებაზიანის შემცირება
ზიანის შემცირება
 
ოპიოიდებით და სტიმულატორებით გამოწვეული ზედოზირების ნიშნები
ოპიოიდებით და სტიმულატორებით გამოწვეული ზედოზირების ნიშნებიოპიოიდებით და სტიმულატორებით გამოწვეული ზედოზირების ნიშნები
ოპიოიდებით და სტიმულატორებით გამოწვეული ზედოზირების ნიშნები
 
ნალოქსონის გამოყენება ოპიოიდებით ზედოზირებისას
ნალოქსონის გამოყენება ოპიოიდებით ზედოზირებისასნალოქსონის გამოყენება ოპიოიდებით ზედოზირებისას
ნალოქსონის გამოყენება ოპიოიდებით ზედოზირებისას
 
Comprehensive Women‐Centered Treatment for Substance Use in Georgia (country)...
Comprehensive Women‐Centered Treatment for Substance Use in Georgia (country)...Comprehensive Women‐Centered Treatment for Substance Use in Georgia (country)...
Comprehensive Women‐Centered Treatment for Substance Use in Georgia (country)...
 
საველე სოციალური მუშაობა ნარკოტიკების ინექციურ მომხმარებლებთან (აუთრიჩი)
საველე სოციალური მუშაობა ნარკოტიკების ინექციურ მომხმარებლებთან (აუთრიჩი)საველე სოციალური მუშაობა ნარკოტიკების ინექციურ მომხმარებლებთან (აუთრიჩი)
საველე სოციალური მუშაობა ნარკოტიკების ინექციურ მომხმარებლებთან (აუთრიჩი)
 
სარისკო ქცევა, რისკის შეფასება და ქცევის ცვლილების ეტაპები
სარისკო ქცევა, რისკის შეფასება დაქცევის ცვლილების ეტაპებისარისკო ქცევა, რისკის შეფასება დაქცევის ცვლილების ეტაპები
სარისკო ქცევა, რისკის შეფასება და ქცევის ცვლილების ეტაპები
 
Drug use patterns among participants in a woman-focused RCT in Georgia
Drug use patterns among participants in a woman-focused RCT in GeorgiaDrug use patterns among participants in a woman-focused RCT in Georgia
Drug use patterns among participants in a woman-focused RCT in Georgia
 
 Stigma, violence, and the lack of confidentiality: The need for comprehensi...
 Stigma, violence, and the lack of confidentiality:  The need for comprehensi... Stigma, violence, and the lack of confidentiality:  The need for comprehensi...
 Stigma, violence, and the lack of confidentiality: The need for comprehensi...
 
Risk and stigma in seeking care and policy implications
Risk and stigma in seeking care and policy implicationsRisk and stigma in seeking care and policy implications
Risk and stigma in seeking care and policy implications
 
Influence of social norms and attitudes on drug use and HIV risk behavior amo...
Influence of social norms and attitudes on drug use and HIV risk behavior amo...Influence of social norms and attitudes on drug use and HIV risk behavior amo...
Influence of social norms and attitudes on drug use and HIV risk behavior amo...
 
A formative study of drug-using women in Georgia: Setting the Stage for an RCT
A formative study of drug-using women in Georgia: Setting the Stage for an RCTA formative study of drug-using women in Georgia: Setting the Stage for an RCT
A formative study of drug-using women in Georgia: Setting the Stage for an RCT
 
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...
 

Recently uploaded

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
rightmanforbloodline
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 

Recently uploaded (20)

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 

Understanding changing patterns of drug use in georgia

  • 1. Understanding changing patterns of drug use in Georgia: Implications for service delivery and policy development DDavid Otiashvili, M.D. Irma Kirtadze, M.D. Addiction Research Center, Alternative Georgia Global Addiction Conference Piza, Italy May 7, 2013
  • 2. Brief information on Georgia Indicator Info for 2011 Surface area 69.700 sq km Population 4.497.6 m GDP per capita in PPS 2549.09 euro Unemployment rate 15.1% Prison Population Rate (per 100.000) 524
  • 3. Drug use • General population No data • Problem drug use 40,000 (95% CI: 39,000-41,000) prevalence 1.5% among 15-64 years old • Drugs injected shift from traditional opium, heroine and buprenorphine to home-made ATS (“vint”, “jef”) and opioids (desomorphine, “krokodile”)
  • 5. Abuse of over the counter medications • 2003 – explosive abuse of poppy seeds • 2005-2008 – injection use of Coaxil (Tianeptin) • 2010-2011 – widespread oral consumption of anticonvulsant Lyrica (Pregabalin)
  • 6. Common features of Georgian drug scene • Drugs use intravenously (no sniffing, smoking or inhaling) • Daily dose is low • Opioids combined with sedatives • Unstructured poli-drug use is common
  • 7. Drug use trends shaped by socio- economic and policy context • Buprenorphine abuse • Home-made stimulants • Home-made opioids • Poppy seeds, Coaxil, Lyrica
  • 8. New drugs – new harms • Injection risk behavior • Toxicity • Overdose
  • 9. New cases of HIV infection, 1990- 2011
  • 10. 306 300 609 911 1082 841 584 338 270 0 0 8 130 285 552 1200 2118 2352 0 500 1000 1500 2000 2500 3000 2003 2004 2005 2006 2007 2008 2009 2010 2011 OST detox Treatment response
  • 11. Treatment response • No comprehensive treatment approach – Treatment planning – Case management – Continuum of care • No gender-focused services
  • 12. 12 Drug legislation • Drug use (trace of controlled substance in urine) is punishable under the Administrative Code • Repeated drug use is punishable under the Criminal Code (up to 1 year imprisonment) • Possession of ANY amount of drugs, regardless of purpose, is punishable under the Criminal Code • Tables of quantities of drugs (any amount of amphetamine – 7 to 14 years)
  • 13. Prison population 0 5000 10000 15000 20000 25000 30000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
  • 14. Disproportionate resource allocation • Coverage of treatment – 6% • 6,500 adults received health service vs 27,000 episodes of drug testing and police investigation
  • 15. Major policy reform needed • 2013 – Drug Policy Coordination Council • National Drug Strategy • Action Plan • Legislative proposal HEALTH CARE PROFESSIONALS’ ENGAGEMENT CRITICAL!